| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/15/1994 | CA1327745C Product containing as active ingredients : a) a peptide having a human immune interferon like activity, b) hydroxyurea |
| 03/12/1994 | CA2105959A1 Aryl urea (thiourea) and cyanoguanidine derivatives |
| 03/12/1994 | CA2105958A1 Aryl and heterocycle substituted propenamide derivatives |
| 03/12/1994 | CA2105934A1 Cyclic urea derivatives |
| 03/12/1994 | CA2105913A1 Adsorbate of an auxiliary mixture and a non-solid active compound for the preparation of pharmaceutical compositions |
| 03/12/1994 | CA2105811A1 Enhanced chemotherapeutic compositions against microbial infections in fish, the preparation and use thereof |
| 03/11/1994 | CA2105816A1 Substituted phenols, processes for their preparation and their use for the treatment of disorders caused by cell proliferation |
| 03/11/1994 | CA2105614A1 3-aryl-pyrone derivatives |
| 03/11/1994 | CA2105598A1 Compounds useful as hypoglycemic agents and for treating alzheimer's disease |
| 03/10/1994 | DE4230053A1 4-Oxo-azetidin-2-sulfonsäureamide und ihre Salze, Verfahren zu deren Herstellung und ihre Verwendung 4-oxo-azetidine-2-sulfonic acid amides and their salts, processes for their preparation and their use |
| 03/10/1994 | DE4229707A1 Germicide Wirkstoffkombinationen Germicides drug combinations |
| 03/10/1994 | CA2105746A1 Process for preparing carbapenem and penem compounds and new compounds involved in that process |
| 03/10/1994 | CA2105708A1 Heteroarenylpiperazines, a process for their preparation and their use as medicaments |
| 03/10/1994 | CA2105707A1 Substituted cyclohexane derivatives for the treatment of diseases |
| 03/10/1994 | CA2105693A1 Benzopyran compounds, process for the preparation thereof and pharmaceutical compositions containing them |
| 03/10/1994 | CA2105599A1 Prevention of bone resorption |
| 03/09/1994 | EP0586344A1 Oxazolidene derivatives and their use as pharmaceuticals |
| 03/09/1994 | EP0586298A1 Inhibitor of herpes simplex viral thymidine kinase |
| 03/09/1994 | EP0586282A1 Topical compositions containing 5-methoxypsoralene |
| 03/09/1994 | EP0586254A1 Furanoindoline derivatives and their use as antitumor agents |
| 03/09/1994 | EP0586191A1 Monohydrate of 5-(2-(4-(1,2 Benzisothiazol-3-YL)-1-Piperazinyl)-Ethyl)-6-Chloro-1,3-Dihydro-2H-indol-2-one Hydrochloride |
| 03/09/1994 | EP0586106A1 Skin care compositions containing imidazoles and retinoids |
| 03/09/1994 | EP0586085A2 Veterinary method for the treatment of ketosis in livestock |
| 03/09/1994 | EP0586034A2 High pullulan content product, and its preparation and uses |
| 03/09/1994 | EP0586020A1 Tetracyclines alone or in combination with NSAID for treating tissue destruction |
| 03/09/1994 | EP0585896A1 Medicament for tropical application at the eye for the treatment of increased intraocular pressure |
| 03/09/1994 | EP0585728A1 Use of dithiolylidene malonate derivatives for the prevention of metastasis |
| 03/09/1994 | EP0585722A1 Benzimidazole derivatives as antimicrobal agent against Campylobacter pylon |
| 03/09/1994 | EP0585500A1 Diaryl piperazineacetamides as antimuscarinic agents |
| 03/09/1994 | EP0585399A1 Treatment of colorectal carcinoma with antisense oligonucleotides to c-myb proto-oncogene |
| 03/09/1994 | EP0585383A1 Chemical compounds |
| 03/09/1994 | EP0585371A1 Aromatic oligomeric compounds useful as mimics of bioactive macromolecules |
| 03/09/1994 | EP0585366A1 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood |
| 03/09/1994 | EP0585337A1 Method of suppressing tumor formation in vivo by administering je/mlp-1 |
| 03/09/1994 | EP0585328A1 Substituted 3-aminoquinuclidines |
| 03/09/1994 | EP0585296A1 2-(pyrrolidinyl-1-methyl)-piperidine derivatives and their use as kappa-recept or agonists |
| 03/09/1994 | EP0585267A1 Herpesvirus particles and vaccine |
| 03/09/1994 | EP0585252A1 Pharmaceutical formulations |
| 03/09/1994 | EP0585242A1 Wound healing |
| 03/09/1994 | EP0526588B1 Heterocyclic compounds and their preparation and use |
| 03/09/1994 | EP0439544B1 In vivo neurotrophic cytoprotective alcohols |
| 03/09/1994 | EP0420914B1 Cosmetic and skin treatment compositions |
| 03/09/1994 | EP0417210B1 Novel o-(3-amino-2-hydroxypropyl)-hydroximic acid halides and process for preparing the same |
| 03/09/1994 | EP0365662B1 Antiglaucoma compositions containing combinations of alpha-2 agonists and beta-blockers |
| 03/09/1994 | EP0341300B1 Stimulation of stem cell growth by the bryostatins |
| 03/09/1994 | EP0262207B1 Beta-lactam antibiotics |
| 03/09/1994 | CN1083487A New preparation process for 16alpha-methyl steroids |
| 03/09/1994 | CN1083486A Heteroatoms-containing tricyclic compounds |
| 03/09/1994 | CN1083485A Benzothiazepine and benzoxazepine derivatives |
| 03/09/1994 | CN1083481A 4,1-benzoxazep in derivatives and their use |
| 03/09/1994 | CN1083480A Process for the preparation of substituted benzenes and benzene sulfonic acid and derivatives thereof and a process for the preparation of N,N'-substituted ureas |
| 03/09/1994 | CN1083477A 4-Iminochinolin and preparation and application of same |
| 03/09/1994 | CN1083476A Quinoline derivative fumarates |
| 03/09/1994 | CN1083475A Chemical compounds |
| 03/09/1994 | CN1083473A Novel compounds |
| 03/09/1994 | CN1083472A Novel antioxidants |
| 03/09/1994 | CN1083471A Substituted cinnamic acid and its salt derivatives with central inhibition function |
| 03/09/1994 | CN1083360A Runshu eye drops and making method thereof |
| 03/09/1994 | CN1083359A 人体润滑剂 Human Lubricants |
| 03/09/1994 | CN1083358A Oral care compositions comprising certain substituted dephenyl ethers |
| 03/09/1994 | CN1083357A Anti-rheumatic |
| 03/09/1994 | CN1083356A Hemostatic-Jianshensu granule |
| 03/09/1994 | CN1023938C Process for preparing naphthyl oxazolididone derivatives |
| 03/09/1994 | CN1023934C Preparation of compound rifampin (RFP) capsules |
| 03/09/1994 | CA2101571A1 Crystalline dihydrate of a cephalosporin dihydrate salt and injectable compositions thereof |
| 03/08/1994 | US5292921 Intermediates for antitumor agents |
| 03/08/1994 | US5292906 Tricyclic steroid analogs |
| 03/08/1994 | US5292887 Substituted imidazole derivatives and their preparation and use |
| 03/08/1994 | US5292878 17-spirofuran-3'-ylidene steroids |
| 03/08/1994 | US5292775 Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment |
| 03/08/1994 | US5292774 Substitution fluid preparation comprising 3-hydroxy-butyric acid (β-hydroxybutric acid) and its salts |
| 03/08/1994 | US5292773 Treating aids and HIV infection with methionine |
| 03/08/1994 | US5292772 Method for the prevention and control of epileptic seizure associated with Lennox-Gastaut syndrome |
| 03/08/1994 | US5292771 Treating inflammatory bowel disease |
| 03/08/1994 | US5292769 Substituted mandelic acid derivatives and their use in medicaments |
| 03/08/1994 | US5292767 Treatment of autoimmune diseases |
| 03/08/1994 | US5292766 Method for improving primary memory and/or learning |
| 03/08/1994 | US5292765 Neuroprotection by indolactam V and derivatives thereof |
| 03/08/1994 | US5292761 Piperidine, tetrahydropyridine and pyrrolidine compounds |
| 03/08/1994 | US5292758 Sulfonamide derivatives |
| 03/08/1994 | US5292756 Novel sulfonamide fibrinogen receptor antagonists |
| 03/08/1994 | US5292755 USPA benzolyguanidines |
| 03/08/1994 | US5292753 Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof in pharmaceutical compositions and animal feeds |
| 03/08/1994 | US5292751 5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-(1-propyl))piperidinyl)-4H-1-benzopyran-4-one, its preparation and its use |
| 03/08/1994 | US5292750 Therapeutic agents |
| 03/08/1994 | US5292749 Antimuscarinic bronchodilators |
| 03/08/1994 | US5292745 Use of 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine derivatives as free radical scavengers |
| 03/08/1994 | US5292740 Sulfonamides |
| 03/08/1994 | US5292739 Aryl(or heteroaryl) piperazinylalkylazole derivatives, their preparation and their application as medicaments |
| 03/08/1994 | US5292738 Anti-virally active pyridazinamines |
| 03/08/1994 | US5292736 Morpholinoalkylindenes as antiglaucoma agents |
| 03/08/1994 | US5292735 Cyclic amide derivatives |
| 03/08/1994 | US5292733 Cephalosporin compounds |
| 03/08/1994 | US5292732 Pyrrolopyrazine derivatives |
| 03/08/1994 | US5292731 Methods of treatment using methotrexate compositions |
| 03/08/1994 | US5292730 Modulation of immune system with Δ5-androstenes |
| 03/08/1994 | US5292729 II-bond aromatic vitamin chelates |
| 03/08/1994 | US5292727 Administering calcipotriol |
| 03/08/1994 | US5292723 Liquid nutritional compositions comprising slowly absorbed glucides |
| 03/08/1994 | US5292722 Dextrose and glutamine |